Scaling up microbial manufacturing remains one of the most complex and often underestimated challenges across the development lifecycle. While many programs advance successfully through early stages, delays and complications frequently emerge as assets move toward late clinical and commercial manufacturing, particularly at key inflection points.
In this on-demand webinar, we explore five critical scale-up principles observed across high-performing microbial programs, drawing on industry insights from early development through late-stage and commercial readiness.
- Where scale-up risks most commonly emerge and how to recognize these pressure points early
- The difference between a process that performs well today and one that is truly robust, scalable, and defensible
- How analytics, process understanding, and comparability must evolve as programs scale
